0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......


Basic View | Expanded View
 Showing 1-16 of 16 Articles
Viewpoint  FREE
Philip Rocco, PhD; Walid F. Gellad, MD, MPH; Julie M. Donohue, PhD

This Viewpoint discusses CMS’ proposed overhaul of Medicaid’s managed care programs.

Original Investigation  FREE
Line Melgaard, MSc; Anders Gorst-Rasmussen, MSc, PhD; Deidre A. Lane, PhD; Lars Hvilsted Rasmussen, MD, PhD; Torben Bjerregaard Larsen, MD, PhD; Gregory Y. H. Lip, MD
Includes: Supplemental Content

Importance  The CHA2DS2-VASc score (congestive heart failure, hypertension, age ≥75 years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled], vascular disease [prior myocardial infarction, peripheral artery disease, or aortic plaque], age 65-75 years, sex category [female]) is used clinically for stroke risk stratification in atrial ...

Viewpoint  FREE
Mitchell W. Krucoff, MD; Art Sedrakyan, MD, PhD; Sharon-Lise T. Normand, PhD
Includes: Supplemental Content

This Viewpoint proposes implementation of strategic coordinated registries networks as the foundation for a national surveillance system that inform decisions about medical device safety, effectiveness, and quality.

Viewpoint  FREE
Jing Luo, MD; Aaron S. Kesselheim, MD, JD, MPH

This Viewpoint discusses the importance of patent protection and its role in the Trans-Pacific Partnership (TPP) Agreement.

Medical News & Perspectives  FREE
Michael Berkwits, MD, MSCE

In this Medical News and Perspectives interview, Richard Kronick, PhD, Director of the Agency for Healthcare Research and Quality, discusses the mission of the agency and its relationship with other federal health research entities.

Viewpoint  FREE
Arthur L. Kellermann, MD, MPH; Nihar R. Desai, MD, MPH

This Viewpoint discusses obstacles and policy options for the development and adoption of cost-lowering health technologies in the United States.

Viewpoint  FREE
Tim Xu, MPP; Albert W. Wu, MD, MPH; Martin A. Makary, MD, MPH

This Viewpoint discusses the implications of the growing trend of hospital consolidation for quality, access, and price of care.

Viewpoint  FREE
William H. Shrank, MD, MSHS; Jane F. Barlow, MD, MPH; Troyen A. Brennan, MD, JD

This Viewpoint discusses the need to achieve consensus around management strategies for patients with hyperlipidemia when proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors enter the marketplace.

Viewpoint  FREE
Howard K. Koh, MD, MPH; Rima E. Rudd, ScD, MSPH

This Viewpoint discusses potential roles for clinicians, institutions, and systems in increasing health literacy at both the individual patient and population level.

Topics: health literacy
Viewpoint  FREE
David C. Classen, MD, MS; Leonard A. Mermel, DO, ScM

This Viewpoint discusses challenges of developing and implementing clinical practice guidelines.

Viewpoint  FREE
Gary S. Kaplan, MD

This Viewpoint discusses the importance of timeliness in quality of health care and summarizes strategies for improving wait times and access to care.

Viewpoint  FREE
Y. Tony Yang, ScD, LLM, MPH; Leila Barraza, JD, MPH; Kim Weidenaar, JD

This Viewpoint discusses how a recent measles outbreak may lead to tightening of US school immunization laws and describes the recent passage of such a law in California as an example other states might follow.

Viewpoint 
Steven J. Katz, MD, MPH; Allison W. Kurian, MD, MSc; Monica Morrow, MD

This Viewpoint discusses the tension between increased availability of genetic testing and the usefulness of test results for clinical decision making in the context of breast cancer.

Viewpoint  FREE
Harold Alan Pincus, MD; Mary Jane England, MD

This Viewpoint discusses an Institute of Medicine framework for improving the quality of psychosocial interventions delivered to persons with mental health and substance use disorders.

Viewpoint  FREE
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS

This Viewpoint discusses the history of flibanserin and provides insight about the regulatory process.

Viewpoint 
Michael J. Joyner, MD; Nigel Paneth, MD, MPH

This Viewpoint discusses the promise of personalized or precision medicine compared with its achievements to date.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts